CLIA Condition-Level Deficiencies: CMS Penalties and Corrections

A CLIA condition-level deficiency is a finding by the Centers for Medicare & Medicaid Services that a clinical laboratory has failed an entire category of compliance required under the Clinical Laboratory Improvement Amendments, not just a single rule within it. The label matters because it unlocks CMS’s full enforcement arsenal: civil money penalties that reach $26,262 per day, directed plans of correction, state onsite monitoring, and suspension, limitation, or revocation of the laboratory’s certificate.¹

How It Differs From a Standard-Level Finding

CMS inspections measure laboratories against requirements organized into broad conditions and narrower standards inside each condition. A standard-level deficiency means the lab missed a specific rule but not in a way that undermines the whole category. A condition-level deficiency is the conclusion that the noncompliance, by its severity or its spread, has taken the entire condition out of compliance.²

That reclassification is what changes the stakes. Standard-level deficiencies require correction but do not, on their own, expose a laboratory to principal sanctions. Condition-level findings do. A laboratory can be cited at the condition level even for violating a single component of a multi-part regulation, so long as the severity or extent justifies treating the whole condition as failed. The count of individual deficiencies matters less than what they collectively say about the reliability of the lab’s results.

A few examples show how varied the triggers can be. A missing qualified laboratory director or technical supervisor can produce a condition-level citation by itself. Unsuccessful proficiency testing performance, defined as failing to achieve a satisfactory score on two consecutive events or two out of three consecutive events, is another common route.³ Breakdowns anywhere in the quality system, from sample labeling before testing through the accuracy of the final report, can also rise to this level.

When It Becomes Immediate Jeopardy

Not every condition-level deficiency is treated the same. CMS applies an immediate jeopardy designation when noncompliance has caused, is causing, or is likely to cause serious injury, harm, or death. It is the highest severity tier in the CLIA framework, and it compresses every timeline that follows.⁴

Surveyors must confirm three things before making the call: the laboratory is out of compliance with a condition-level requirement, serious harm has occurred or is likely, and immediate corrective action is necessary to prevent further harm. The harm threshold covers significant decline in physical or mental functioning, loss of limb, disfigurement, or avoidable pain beyond transient discomfort.

When immediate jeopardy is confirmed and a follow-up visit shows the laboratory has not eliminated it, CMS can suspend or limit the certificate with as little as five days’ notice.⁵ Compare that to the ordinary enforcement track, which typically allows months for correction, and the difference is the whole point.

Penalties CMS Can Impose

CMS separates its enforcement tools into principal sanctions and alternative sanctions. Principal sanctions are certificate suspension, limitation, or revocation. Alternative sanctions include civil money penalties, directed plans of correction, and state onsite monitoring. CMS can impose alternative sanctions on their own or alongside principal ones.¹

Civil Money Penalties

The penalty range turns on whether the deficiency poses immediate jeopardy. The base regulatory range is $3,050 to $10,000 per day or per violation for condition-level deficiencies with immediate jeopardy, and $50 to $3,000 per day or per violation for those without it.⁶ Those numbers are adjusted annually for inflation. As of 2026, the inflation-adjusted maximums are $26,262 per day for immediate jeopardy deficiencies and $7,877 per day for non-immediate jeopardy deficiencies.⁷ CMS also considers whether the same condition-level deficiencies have appeared in three consecutive inspections and can escalate fines for repeat noncompliance.

Directed Corrective Action and State Monitoring

A directed plan of correction requires the laboratory to follow specific remedial steps set by CMS, rather than designing its own approach. CMS may also appoint a state monitor to observe daily operations during remediation and confirm in real time that the facility is meeting its obligations.

Suspension, Limitation, and Revocation

Limitation restricts the laboratory to specific tests. Suspension halts all testing temporarily. Revocation ends the laboratory’s authority to operate and bars the owner and operator from running any CLIA-certified laboratory for at least one year.⁸ CMS can also cancel Medicare and Medicaid payment approval, cutting off a major revenue stream even before formal revocation is final.

One category sits outside all of this. Intentional referral of proficiency testing samples to another laboratory triggers automatic revocation for at least one year, plus a one-year ban on the owner and operator from running any CLIA-certified lab.⁸

How Long You Have to Fix It

For condition-level deficiencies without immediate jeopardy, a laboratory generally has up to 12 months from the last day of the inspection to correct all condition-level findings. If it does not, CMS cancels the lab’s Medicare approval and moves to suspend, limit, or revoke the certificate.⁹

A shorter three-month deadline runs alongside it for Medicare payments. If the condition-level deficiencies are not corrected within three months from the last date of inspection, CMS can suspend all Medicare payments for covered laboratory services. The 12-month window is still open, but the revenue stops.

Submitting the Plan of Correction

Findings arrive on Form CMS-2567, which lists every deficiency identified during the survey.¹⁰ The laboratory then has 10 calendar days from receiving the form to submit a completed plan of correction to the state survey agency or CMS regional office. Missing that deadline can prompt further enforcement action before remediation has even started.

The plan must address each cited deficiency on its own terms. For every finding, the laboratory needs to explain what corrective action it took to fix the immediate problem, what systemic changes will prevent recurrence, who is responsible for monitoring the new protocols, and the completion date for each item. General statements do not pass review; CMS looks for specific steps tied to specific people and specific timelines. The laboratory director or authorized representative signs and dates the form.¹⁰ Training records, revised policy manuals, and updated standard operating procedures typically go in as supporting evidence. CMS then accepts the submission, requests revisions, or rejects it outright.

What Happens After You Submit

An approved plan of correction does not close the case. CMS or its state survey agency can conduct an unannounced follow-up inspection at any time during operating hours to verify that the corrections were actually implemented.¹¹ A laboratory may also submit a credible allegation of compliance with supporting evidence, and CMS decides whether documentation is enough or whether an onsite visit is needed.

If the follow-up confirms the deficiencies were corrected before the visit, sanctions are lifted as of the earlier compliance date. If the deficiencies persist, CMS can propose to suspend, limit, or revoke the certificate. At that point the process shifts from corrective to punitive.

Appeals, and What Keeps Running During Them

A laboratory that disagrees with a sanction has 60 days from the date of the notice to request a hearing before an Administrative Law Judge.¹² The question that usually matters more than the appeal itself is whether the sanction stays in force while it is pending.

Certificate suspension, limitation, or revocation is generally delayed until the ALJ decides. It is not delayed if CMS finds immediate jeopardy, or if the laboratory has refused to allow inspections or provide requested information. In those cases the action takes effect right away.
Alternative sanctions other than civil money penalties, such as a directed plan of correction or state monitoring, remain in effect during the appeal.
Cancellation of Medicare approval is not delayed by the appeal. The laboratory loses Medicare payment authorization while it litigates.

Because most laboratories cannot absorb the loss of Medicare payments through a lengthy appeals process, CMS often secures compliance without ever reaching a hearing.

Public Reporting Through the Laboratory Registry

Enforcement actions do not stay private. Federal law requires CMS to compile and publish a Laboratory Registry annually.¹³ It lists laboratories whose certificates have been suspended, limited, or revoked; laboratories on which alternative sanctions have been imposed; all appeals and hearing decisions; and laboratories excluded from Medicare or Medicaid participation. It also states the reasons for each action and, where applicable, the date the laboratory returned to compliance. For a laboratory that depends on referring physicians, that public record can outlast the sanction itself.

Accreditation by an approved body such as CAP, COLA, or the Joint Commission does not remove any of this. CMS retains authority to conduct validation and complaint inspections at accredited laboratories, and a condition-level finding on one of those visits produces the same enforcement exposure described above.¹⁴

1
eCFR. 42 CFR 493.1806 – Available Sanctions
2
Centers for Medicare & Medicaid Services. Principles of Documentation
3
eCFR. 42 CFR Part 493 – Laboratory Requirements – Section 493.801
4
Centers for Medicare & Medicaid Services. State Operations Manual Appendix Q – Core Guidelines for Determining Immediate Jeopardy
5
eCFR. 42 CFR 493.1812 – Action When Deficiencies Pose Immediate Jeopardy
6
eCFR. 42 CFR 493.1834 – Civil Money Penalty
7
Federal Register. Annual Civil Monetary Penalties Inflation Adjustment
8
eCFR. 42 CFR 493.1840 – Suspension, Limitation, or Revocation of Any Type of CLIA Certificate
9
eCFR. 42 CFR Part 493 – Laboratory Requirements – Section 493.1814
10
Centers for Medicare & Medicaid Services. Statement of Deficiencies and Plan of Correction (CMS-2567)
11
eCFR. 42 CFR Part 493 – Laboratory Requirements – Section 493.1820
12
eCFR. 42 CFR 493.1844 – Appeals Procedures
13
Centers for Medicare & Medicaid Services. Laboratory Registry
14
Centers for Medicare & Medicaid Services. Appendix C – Survey Procedures and Interpretive Guidelines for Laboratories